Optimisation of Embryonic and Larval ECG Measurement in Zebrafish for Quantifying the Effect of QT Prolonging Drugs

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Dhillon, Sundeep Singh ^a,b   Dóró, Éva ^a,d   Magyary, István ^b,e   Egginton, Stuart ^a,c   Sík, Attila ^a   Müller, Ferenc ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; PENICILLIN DERIVATIVE; TERFENADINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TESTING REPLACEMENT; ARTICLE; ARTIFACT; CARDIOTOXICITY; CONTROLLED STUDY; DRUG SCREENING; ELECTROCARDIOGRAM; EMBRYO; LARVA; NONHUMAN; QT PROLONGATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING; ZEBRA FISH;

ANIMALS; ARTIFACTS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; ELECTROCARDIOGRAPHY; HEART; ION CHANNELS; REPRODUCIBILITY OF RESULTS; ZEBRAFISH;

ANIMALIA; DANIO RERIO; MAMMALIA;

EID: 84875973584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060552     Document Type: Article

References (56)

1. Sanguinetti MC, Mitcheson JS, (2005) Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends in Pharmacological Sciences 26: 119-124 doi:10.1016/j.tips.2005.01.003.
2. Milan DJ, (2006) In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. AJP: Heart and Circulatory Physiology 291: H269-H273 doi:10.1152/ajpheart.00960.2005.
3. MacRae CA, (2010) Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery. Expert Opin Drug Discov 5: 619-632 doi:10.1517/17460441.2010.492826.
4. Crumb W, Cavero I, (1999) QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. Pharmaceutical Science & Technology Today 2: 270-280 doi:10.1016/S1461-5347(99)00172-8.
5. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, et al. (2003) Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58: 32-45.
6. Mittelstadt SW, Hemenway CL, Craig MP, Hove JR, (2008) Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods 57: 100-105 doi:10.1016/j.vascn.2007.10.004.
7. Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F, (2005) QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development. Medicinal Research Reviews 25: 133-166 doi:10.1002/med.20019.
8. Letamendia A, Quevedo C, Ibarbia I, Virto JM, Holgado O, et al. (2012) Development and Validation of an Automated High-Throughput System for Zebrafish In Vivo Screenings. PLoS ONE 7: e36690 doi:10.1371/journal.pone.0036690.
9. Berghmans S, Butler P, Goldsmith P, Waldron G, Gardner I, et al. (2008) Zebrafish based assays for the assessment of cardiac, visual and gut function-potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 58: 59-68 doi:10.1016/j.vascn.2008.05.130.
10. Hecker L, Khait L, Sessions SK, Birla RK, (2008) Functional evaluation of isolated zebrafish hearts. Zebrafish 5: 319-322 doi:10.1089/zeb.2008.0550.
11. Hassel D, Scholz EP, Trano N, Friedrich O, Just S, et al. (2008) Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. Circulation 117: 866-875 doi:10.1161/CIRCULATIONAHA.107.752220.
12. Leong IUS, Skinner JR, Shelling AN, Love DR, (2010) Zebrafish as a model for long QT syndrome: the evidence and the means of manipulating zebrafish gene expression. Acta Physiol (Oxf) 199: 257-276 doi:10.1111/j.1748-1716.2010.02111.x.
13. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, et al. (1996) Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 123: 285-292.
14. Rottbauer W, Baker K, Wo ZG, Mohideen MA, Cantiello HF, et al. (2001) Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell 1: 265-275.
15. Lieschke GJ, Currie PD, (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8: 353-367 doi:10.1038/nrg2091.
16. Langheinrich U, (2003) Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 25: 904-912 doi:10.1002/bies.10326.
17. Goldsmith P, (2004) Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol 4: 504-512 doi:10.1016/j.coph.2004.04.005.
18. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, et al. (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nature Chemical Biology 1: 366-370 doi:10.1038/nchembio749.
19. Sun P, Zhang Y, Yu F, Parks E, Lyman A, et al. (2009) Micro-Electrocardiograms to Study Post-Ventricular Amputation of Zebrafish Heart. Annals of Biomedical Engineering 37: 890-901 doi:10.1007/s10439-009-9668-3.
20. Forouhar AS, Hove JR, Calvert C, Flores J, Jadvar H, et al. (2004) Electrocardiographic Characterization of Embryonic Zebrafish. 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2004. IEMBS '04. IEEE, Vol. 2: 3615-3617 doi:10.1109/IEMBS.2004.1404016.
21. Milan DJ, Kim AM, Winterfield JR, Jones IL, Pfeufer A, et al. (2009) Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 120: 553-559 doi:10.1161/CIRCULATIONAHA.108.821082.
22. Yu F, Huang J, Adlerz K, Jadvar H, Hamdan MH, et al. (2010) Evolving Cardiac Conduction Phenotypes in Developing Zebrafish Larvae: Implications to Drug Sensitivity. Zebrafish 7: 325-331 doi:10.1089/zeb.2010.0658.
23. Chablais F, Veit J, Rainer G, Jaźwińska A, (2011) The zebrafish heart regenerates after cryoinjury-induced myocardial infarction. BMC Developmental Biology 11: 21 doi:10.1186/1471-213X-11-21.
24. Tsai C-T, Wu C-K, Chiang F-T, Tseng C-D, Lee J-K, et al. (2011) In-vitro recording of adult zebrafish heart electrocardiogram- a platform for pharmacological testing. Clin Chim Acta 412: 1963-1967 doi:10.1016/j.cca.2011.07.002.
25. Yu F, Zhao Y, Gu J, Quigley KL, Chi NC, et al. (2012) Flexible microelectrode arrays to interface epicardial electrical signals with intracardial calcium transients in zebrafish hearts. Biomed Microdevices 14: 357-366 doi:10.1007/s10544-011-9612-9.
26. Yoshida M, Hirano R, Shima T, (2009) Photocardiography: a novel method for monitoring cardiac activity in fish. Zool Sci 26: 356-361 doi:10.2108/zsj.26.356.
27. Fink M, Callol-Massot C, Chu A, Ruiz-Lozano P, Belmonte JCI, et al. (2009) A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. Biotechniques 46: 101-113 doi:10.2144/000113078.
28. Sabeh M, Kekhia H, MacRae C (n.d.) Optical Mapping in the Developing Zebrafish Heart. Pediatric Cardiology: 1-7. doi:10.1007/s00246-012-0300-1.
29. Tsutsui H, Higashijima S-I, Miyawaki A, Okamura Y, (2010) Visualizing Voltage Dynamics in Zebrafish Heart. J Physiol 588: 2017-2021 doi:10.1113/jphysiol.2010.189126.
30. Ripoll C, Lederer WJ, Nichols CG, (1990) Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356. Journal of Pharmacology and Experimental Therapeutics 255: 429-435.
31. Somogyi A, Albrecht M, Kliems G, Schafer K, Eichelbaum M, (1981) Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis. British Journal of Clinical Pharmacology 12: 51-60 doi:10.1111/j.1365-2125.1981.tb01854.x.
32. Gerace E, Salomone A, Pellegrino S, Vincenti M, (2012) Evidence of Haldol (haloperidol) long-term intoxication. Forensic Science International 215: 121-123 doi:10.1016/j.forsciint.2011.01.038.
33. Testai L, Cecchetti V, Sabatini S, Martelli A, Breschi MC, et al. (2010) Effects of KATP openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs. Journal of Pharmacy and Pharmacology 62: 924-930 doi:10.1211/jpp.62.07.0014.
34. Colquhoun D, Dreyer F, Sheridan RE, (1979) The actions of tubocurarine at the frog neuromuscular junction. J Physiol 293: 247-284.
35. Zhang Chung, (1999) Oldenburg (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73.
36. Reyes BA, Pendergast JS, Yamazaki S, (2008) Mammalian Peripheral Circadian Oscillators Are Temperature Compensated. J Biol Rhythms 23: 95-98 doi:10.1177/0748730407311855.
37. Rombough PJ, (2007) Ontogenetic changes in the toxicity and efficacy of the anaesthetic MS222 (tricaine methanesulfonate) in zebrafish (Danio rerio) larvae. Comparative Biochemistry and Physiology- Part A: Molecular & Integrative Physiology 148: 463-469 doi:10.1016/j.cbpa.2007.06.415.
38. Buss RR, Bourque CW, Drapeau P, (2003) Membrane Properties Related to the Firing Behavior of Zebrafish Motoneurons. J Neurophysiol 89: 657-664 doi:10.1152/jn.00324.2002.
39. Maricondi-Massari M, Kalinin AL, Glass ML, Rantin FT, (1998) The effects of temperature on oxygen uptake, gill ventilation and ecg waveforms in the nile tilapia, Oreochromis niloticus. Journal of Thermal Biology 23: 283-290 doi:10.1016/S0306-4565(98)00019-9.
40. Katchman AN, Koerner J, Tosaka T, Woosley RL, Ebert SN, (2006) Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs. J Pharmacol Exp Ther 316: 1098-1106 doi:10.1124/jpet.105.093393.
41. Tran TC, Sneed B, Haider J, Blavo D, White A, et al. (2007) Automated, Quantitative Screening Assay for Antiangiogenic Compounds Using Transgenic Zebrafish. Cancer Res 67: 11386-11392 doi:10.1158/0008-5472.CAN-07-3126.
42. Arrenberg AB, Stainier DYR, Baier H, Huisken J, (2010) Optogenetic control of cardiac function. Science 330: 971-974 doi:10.1126/science.1195929.
43. Tessadori F, Van Weerd JH, Burkhard SB, Verkerk AO, De Pater E, et al. (2012) Identification and Functional Characterization of Cardiac Pacemaker Cells in Zebrafish. PLoS ONE 7: e47644 doi:10.1371/journal.pone.0047644.
44. Spinelli W, Follmer C, Parsons R, Colatsky T, (1990) Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs. European Journal of Pharmacology 179: 243-252 doi:10.1016/0014-2999(90)90162-Y.
45. Jou CJ, Spitzer KW, Tristani-Firouzi M, (2010) Blebbistatin Effectively Uncouples the Excitation-Contraction Process in Zebrafish Embryonic Heart. Cell Physiol Biochem 25: 419-424.
46. Cheng HC, Incardona J, McCullough B, (2006) Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval. J Pharmacol Toxicol Methods 54: 278-287 doi:10.1016/j.vascn.2006.01.002.
47. Martin RL, McDermott JS, Salmen HJ, Palmatier J, Cox BF, et al. (2004) The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J Cardiovasc Pharmacol 43: 369-379.
48. Duan J, Ma J, Zhang P, Wang X, Zou A, et al. (2007) Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain1. Acta Pharmacologica Sinica 28: 959-967 doi:10.1111/j.1745-7254.2007.00562.x.
49. Kojouri GA, Rezakhani A, Torki E, (2007) The Effects of Verapamil Hydrochloride on Electrocardiographic (ECG) Parameters of Domestic Donkey (Equus asinus). Journal of Equine Veterinary Science 27: 499-503 doi:10.1016/j.jevs.2007.10.007.
50. Towart R, Linders JTM, Hermans AN, Rohrbacher J, Van der Linde HJ, et al. (2009) Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? J Pharmacol Toxicol Methods 60: 1-10 doi:10.1016/j.vascn.2009.04.197.
51. Waldegger S, Niemeyer G, Mörike K, Wagner CA, Suessbrich H, et al. (1999) Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes. Cell Physiol Biochem 9: 81-89.
52. Langheinrich U, Vacun G, Wagner T, (2003) Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol 193: 370-382.
53. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, et al. (2000) The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res 47: 219-233 doi:10.1016/S0008-6363(00)00119-X.
54. Warren KS, Fishman MC, (1998) "Physiological Genomics": Mutant Screens in Zebrafish. Am J Physiol Heart Circ Physiol 275: H1-H7.
55. Warren KS, Wu JC, Pinet F, Fishman MC, (2000) The genetic basis of cardiac function: dissection by zebrafish (Danio rerio) screens. Philos Trans R Soc Lond, B, Biol Sci 355: 939-944 doi:10.1098/rstb.2000.0629.
56. Diekmann H, Hill A (n.d.) ADMETox in zebrafish. Drug Discovery Today: Disease Models. Available: http://www.sciencedirect.com/science/article/pii/S1740675712000126. Accessed 2012 Oct 14.